Abstract
IntroduCtIon
K eratoconus is the most common corneal degeneration disease, characterized by cornea conical protrusion, progressive local stroma thinning, increased cornea curvature and irregular astigmatism [1] . The incidence rate of keratoconus is as high as 54.5 per 100 000, which means one person would suffer the disorder within a general population of 2000 [2] .
Spectacles and contact lens, especially rigid gas permeable lens (RGP), are routine ways to treat mild or moderate keratoconus [3] . However, ocular infection, cornea pannus and other complications from improper wearing and poor hygiene habits are not rare [4] . In addition, some studies have suggested that RGP could not halt progressive keratoconus effectively in the long run [5] [6] . Thus, it is essential to exploit new ways to stop the progression of keratoconus more effectively and more safely. In 2003, Wollensak et al [7] first reported their practice of using cross-linking (CXL) to halt progressive keratoconus effectively, and the protocol they used was established as standard cross-linking (SC)-cornea epithelium stripping, riboflavin instillment and 370 nm ultraviolet A (UVA) radiation with an intensity of 3 mW/cm 2 for 30min. Although more and more clinical trials have attested to the effectiveness and safety of SC [8] [9] [10] [11] , complications caused by epithelium stripping and long exposure to ultraviolet radiation, such as unbearable postoperative ocular pain, sub-epithelial haze, sterile infiltration and infectious keratitis, could not be avoided completely [12] . Given that, several modifications have been made to SC to avoid these complications [13] , including keeping the corneal epithelium in situ (trans-epithelial CXL, TC) [14] and using radiation of higher intensity and shorter duration (accelerated CXL, AC) [15] . Although these modified cross-linkings (MCs) are superior to SC at reducing associated complications, it is still controversial whether the ability of MCs to stop progression of keratoconus is equivalent to that of SC. Al Fayez et al [16] reported that Kmax decreased 2.4 D in the SC group while it increased 1.1 D in the TC group postoperatively, which showed more effectiveness for SC in halting progressive keratoconus (P<0.0001). However, Magli et al [17] found equivalent effects between TC and SC since there was no significant difference in terms of Kmax or mean K (P>0.05). This controversial situation is also observed in some studies regarding comparison between AC and SC. Ng et al [18] reported that significant reductions for Kmax and mean K were found in the SC group when compared to AC group (P=0.001 and 0.015, respectively). In contrast, Hashemi et al [19] found that the mean decrease To expand the search, alternative text words used for standard CXL, accelerated CXL and trans-epithelial CXL were "conventional, epithelium-off, epithelium-without CXL", "high-tense, high-fluence CXL" and "epithelium-on, epithelium-with CXL" respectively. Meanwhile, Boolean logic operators, wildcard and position characters were employed to combine the text words to obtain more precise outcomes. In addition, we also scanned the reference lists of included citations to identify any additional reports. However, we did not search any journals or conference proceedings manually, so there was no "gray literature" in this review. 
Studies, Participants and Interventions

Selection of Studies
Two reviewers selected the literatures independently by the same method. Primary selection was conducted through browsing titles and abstracts so that obviously unrelated studies could be excluded; then, the full copies of the remaining studies were obtained to determine whether inclusion or not. At last, the two reviewers compared their reviewing results and solved disagreements with discussion.
Assessment of risk of Bias in Included Studies
The two independent reviewers assessed bias of the included studies by referring to a validated checklist consisted of 14 questions (http://links.lww.com/ICO/A265) [20] . This checklist is suitable for evaluating both RCT and non-RCT, as the 14 questions cover every element of a clinical study. According to the checklist, we defined "long enough follow-up" as 12mo, defined "all important outcomes considered" as primary and main secondary outcomes included in the study, and defined "representative sample" as patients with mild or moderate progressive keratoconus. Three ranks marked "yes", "no" and "unclear" were used to score each question of the checklist and as tudy with 8-9 "yes" answers could be deemed as high qualification [21] . Results from the two independent reviewers 
), a randomized effects pattern was used for pooling the data; otherwise fixed effects was used. A P value of 0.05 was used as the threshold for statistical significance. rESuLtS Study Selection Figure 1 shows the procedure for selecting citations. A total of 628 records were retrieved by searching the electronic databases and by indexing references of related literature. There were 72 duplications and 522 obviously unrelated records, which were recognized by titles and abstracts easily. Then, we excluded 10 citations by browsing full texts, and 24 eligible studies were included finally.
Characteristics of Included Studies
Characteristics of all the 24 eligible studies are shown in Tables 1 and 2 . Among these studies, only one study (4%) [22] was with respect to comparison of the three CXLs,13 studies (54%) [18, [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] were comparing between AC and SC, 10 studies (42%) [16] [17] [35] [36] [37] [38] [39] [40] [41] [42] were on TC versus SC, and as for study design, 11 studies (46%) [16, [26] [27] [28] [32] [33] 35, [39] [40] [41] [42] were RCT, 8 studies (33%) [22] [23] [24] [29] [30] 34, [37] [38] were PCS and 5 studies (21%) [17] [18] 25, 31, 36] were RCS. The sample size varied widely among the studies, the largest sample size enrolled 153 patients (153 eyes) [27] , the smallest one just enrolled 13 patients (13 eyes) [35] , and the sample sizes of most were 30-70 eyes. All the studies enrolled progressive keratoconus patients as their participants. Three studies (13%) [17, 24, 37] took juveniles (less than 18 years old) as their objects, the others (87%) were all adult patients. All eligible studies included both genders, and 18 studies [16-18,22-24,27,29-32,35-41] mentioned the demographic balance within inter-groups. Moreover, the most common participant race was Caucasian (10 studies, 42%) [17, 22, 25, [28] [29] [30] 33, [40] [41] [42] , the others were Mongolian (4 studies, 17%) [18, 23, 31, 43] , Middle
Eastern Ethnicity (4 studies, 17%) [16, 26, 27, 32] , Turks (5 studies, 21%) [24, [35] [36] [37] [38] and Indian (1 study, 4%) [39] . All SC in the studies [16] [17] used UVA radiation for 30min with 3 mW/cm 2 . However, the combinations of duration and intensity used for AC were different in some studies, e.g. 30 mW/cm 2 with 3min, 30 mW/cm 2 with 4min, 18 mW/cm 2 with 5min, 9 mW/cm 2 with 10min, etc [18, [23] [24] [25] [26] [27] [31] [32] [33] . Except for one TC protocol [22] that used 10 mW/cm 2 with 9min, all the other TC followed SC protocol. However, the riboflavin used in TC were different from that in SC and AC, containing some loosened or permeable ingredients, such as EDTA and tromethamine [17, [35] [36] [37] [38] [40] [41] . As an essential process for SC and AC, most studies scraped the corneal epithelium mechanically, but others used excimer laser or chemical means to remove epithelium such as ethanol or topical anesthetics [28, 31] and the diameter of epithelium removal varied in the range of 6.5-10 mm [27] [28] 38] . Although the apparatus and wave length of UVA used in these studies were different, the 365 nm or 370 nm wavelength was the most commonly used except for one study that used 765 nm UVA [39] .
risk of Bias in Included Studies
Qualities of included studies assessed according to the checklist consisted of 14 questions are shown in Table 3 and Figure 2 . The included studies could be considered as qualified, for all of them scored more than 8 "yes" which conformed to our evaluation standard. For each question marked from 1 to 14, "yes" took account for 100% in the questions 1, 5, 10, 14, "no" accounted for more than 50% in the questions 7 and 13, and "unclear" was higher in the questions 4, 8 and 9. 
Effects of Interventions
Comparative outcomes between AC and SC are shown in Table 4 . As shown in Figure 3 , Kmax reduction was significantly greater in SC than in AC; the pooled mean difference of Kmax was 0.49 (95% CI: 0.04-0.94, I 2 =75%, P=0.03). In addition, SE decreased significantly for SC when compared to AC. The mean difference which was 0.62 (95% CI: 0.38-0.86, I 2 =22%, P<0.00001) (Figure 4) . However, comparative outcomes of UDVA, CDVA, DDL, CCT and ECD indicated no significant differences between the two CXLs shown by the pooled data.
When comparing TC to SC, significant difference of Kmax between the groups was observed by pooled mean difference, which was 1.15 (95% CI: 0.54-1.75, I
2 =50%, P=0.0002) ( Figure 5) . Similarly, the DDL of SC was more significantly deeper than that of TC, the mean difference of DDL was -133.49 (95% CI: -145.94 to -121.04, I 2 =33%, P<0.00001) ( Figure 6 ). However, UDVA, CDVA, CCT, ECD and SE demonstrated no significant differences between TC and SC.
The main side effects reported in these studies were delayed epithelium healing and anterior stromal scarring or opacity. In all 24 included studies, only two studies reported postoperative side effects. In one study, Sherif et al [32] mentioned that one patient had infant anterior stromal opacity for one year after SC treatment. In the other study, Shetty et al [33] noticed two [42] Norway patients in the SC group and four patients in the AC group had delayed epithelial healing and two patients had anterior scarring after AC. dISCuSSIon Both SC and MCs have been proved to halt progressive keratoconus effectively by more and more studies [7] [8] [9] [10] [11] [43] [44] [45] [46] , but whether MCs are equivalent to SC in effectiveness has remained unclear. From our Meta-analysis, pooled data showed significant inferiority for MCs relative to SC at halting Kmax deterioration in progressive keratoconus. In addition, SE and DDL showed significant differences when comparing SC with AC and TC, respectively. However, UDVA, CDVA, CCT and ECD demonstrated no significant differences in comparison of MCs and SC. These findings illustrated that SC is superior to MCs athalting progression of keratoconus, but improvements for visual acuity and safety showed equivalence between MCs and SC. The rationale for CXL is mainly about photochemical effects generated from reactions between ultraviolet radiation and riboflavin (vitamin B2) in the cornea stroma. This procedure can lead to more covalent bond formation within cornea lamellar fibers through which the thinner part of the keratoconic cornea can be consolidated and cornea curvature could also be decreased [47] [48] . Moreover, the crosslinked corneal collagen fibers can delay the progression of keratoconus via resisting the intraocular pressure (IOP) effectively [49] . The corneal epithelium is the critical obstacle to riboflavin permeation into the corneal stroma, and it affects CXL's effects significantly because a complete and intact epithelial layer is a tough lipophilic barrier to hydro-soluble riboflavin [11, 47] . Franch et al [50] testified that through an enhancer used in the riboflavin solution, the concentration of riboflavin in epi-on cornea was much lower than in epi-off cornea in vivo. This can explain to a large extent why TC was significantly inferior to SC at halting progression of Kmax value, which was also confirmed by superficial DDL in TC caused by shallower infiltration of riboflavin and lower absorption. Similarly, Wollensak and Iomdina [51] suggested that the therapeutic effect of TC was only about one fifth that of SC. Although the corneal epithelium is also an obstacle for UVA radiation, it is not significant enough to influence CXL's effects. Bottos et al [52] assumed that the main obstacle caused by the cornea epithelium in TC is prevention of riboflavin penetration rather than limitation of UVA transmittance. Other authors estimated that approximately 30% of UVA radiation and approximately 80% of riboflavin could be absorbed by intact cornea epithelium [53] [54] . In contrast to TC, the corneal epithelium is usually removed by mechanical scraping or excimer laser cutting in order to allow more riboflavin to permeate into the cornea stroma in AC and SC [11, 47] . As a standard step for both AC and SC, the riboflavin penetration depth is greater than in TC after the epithelium is removed. In addition, the position that the reactions occur in the corneal stroma should be identical between AC and SC theoretically, because the similar procedures and riboflavin are used. Since DDL indicates the depth of riboflavin permeation and the reacted position in the cornea, this assumption is consistent with our pooled result that DDL was not significantly different between AC and SC. Ultraviolet radiation intensity and duration are other significant factors that influence CXL's effects. Most AC protocols used in the included studies employed different combinations that had an energy dose (5.4 J/cm 2 ) equal to SC, such as 30 mW/cm 2 for 3min and 18 mW/cm 2 for 5min [26] [27] . According to BunsenRoscoe's law of reciprocity that effects of CXL mainly depend on the energy absorbed by tissue [55] [56] , the effect of AC should be equivalent to SC through the similar radiation dose used in these studies. However, we found that it was significantly superior for SC to AC at halting progression of Kmax values by the pooled data. Paralleling to our result, Wernli et al [57] found that higher intensities, e.g. from 50 mW/cm 2 up to 90 mW/cm 2 , could not reach the same stiffness effects as lower intensities did even though they complied with BunsenRoscoe's law. The reasons accounting for this, inferred by some authors, are limitation of intrastromal oxygen diffusion and more oxygen consumption from higher intensity UVA radiation, which could reduce the biomechanical effects of AC [58] . It is somewhat contradictory to explain that UDVA and CDVA from our pooled results for TC and AC could be comparable to SC even though they were inferior to SC at halting the progression of keratoconus. We assume that the effects generated from CXL could not exert enough impact to improve visual acuity and refractive condition dramatically, no matter what CXL protocol is used. In other words, the effects of CXL mainly reflect the biomechanical impact on stiffening the thinning cornea rather than reforming cornea shape. Even though the pooled SE showed more decrease in SC when compared to AC, we assume that the result was caused by one included study [23] that was given too much weight in the analysis.
In most cases, CCT decreases after CXL have been observed regardless of what CXL protocol was used [8] [9] [10] [11] [43] [44] [45] [46] . Greenstein et al [59] explained this phenomenon by compactness of cornea fibers after CXL caused by thermal and photochemical effects, but other authors attribute this to measurement errors from different apparatus [60] . We assume that thermal and photochemical effects are relatively minor for both MCs and SC, so the CCT decrease from the three CXLs did not show any trend of significance in our pooled data. The safety of MCs and SC have been proved by pooled ECD data that indicated reactions between UVA and riboflavin had no influence on endothelial layer [18, 22, 31, [35] [36] [37] . To the best of our knowledge, there is no published Metaanalysis comparing MCs and SC until now, but this Metaanalysis still has some unavoidable limitations. One objective limitation was that the definition criteria for progressive keratoconus, demographic baseline and follow-up period varied within the included studies. Moreover, a small sample size of participants was enrolled in most studies and all of them were single centered, consecutive case serials without randomization. Lastly, different UVA instruments, riboflavin ingredients, surgical procedures and postoperative medications were used in these studies. In the future, accompanied by more participants enrolled into multi-center randomized clinical trials and by standardization for apparatus and riboflavin ingredients, more reliable outcomes should be obtained and more confirmed conclusions could be made. In conclusion, SC was more favorable at halting the progression of keratoconus, but visual acuity improvement showed comparable results between MCs and SC. MCs are more suitable for pediatrics regarding epithelium-on and short duration, and TC could be carried out for patients with cornea thickness less than 400 µm due to its shallower DDL.
